Knowledge Base

What is lethal synthesis?

13 December 2023
2 min read

Compounds that have a certain degree of similarity to the basic metabolites within organisms, compete with or interfere with the utilization of these basic metabolites, or incorporate into the synthesis of biological macromolecules to form pseudo-biomacromolecules, leading to lethal synthesis and consequently affecting cell growth.

Keep Reading
Back to all blogs →
What are neuraminidase inhibitors and how do you quickly get the latest development progress?
Valuable Targets
4 min read
What are neuraminidase inhibitors and how do you quickly get the latest development progress?
13 December 2023
Neuraminidase inhibitors are drugs that target the neuraminidase enzyme, crucial for combating influenza virus infections.
Read →
Brenig Therapeutics Reports BT-0267 LRRK2 Blocker Shows Improved Safety and Significant CSF Blood Levels at Parkinson's Symposium
Latest Hotspot
3 min read
Brenig Therapeutics Reports BT-0267 LRRK2 Blocker Shows Improved Safety and Significant CSF Blood Levels at Parkinson's Symposium
12 December 2023
Brenig Therapeutics Reveals Enhanced Safety Metrics for its LRRK2 Blocker BT-0267 Featuring Notable CSF-to-Blood Concentration at the Parkinson's Disease Symposium.
Read →
Understanding Mcl-1 Inhibitors and Methods to Keep Abreast of Their Recent Developments
Valuable Targets
4 min read
Understanding Mcl-1 Inhibitors and Methods to Keep Abreast of Their Recent Developments
12 December 2023
Mcl-1 inhibitors are drugs that target the Mcl-1 protein, crucial for regulating cell survival and apoptosis.
Read →
Merck Enhances Cancer Drug Offering By Securing Deal with Abbisko for Market Launch of Advanced Stage Drug, Pimicotinib
Latest Hotspot
3 min read
Merck Enhances Cancer Drug Offering By Securing Deal with Abbisko for Market Launch of Advanced Stage Drug, Pimicotinib
12 December 2023
The prominent science and technology corporation, Merck, has declared a formal licensing contract with the Shanghai-based firm Abbisko Therapeutics Co. Ltd.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.